INSIDER
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
01Overview02Daily Brief03Live04Congress05Corporate Insiders06Government Money07Political Influence08Institutions09Washington Network10Follow the Power11Disclosure Clock12AI Investigator13Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
OverviewDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 423m ago
HOUSE PTR22m ago
SEC 13F22m ago
ROBINHOOD CHAIN22m ago
Corporate insider
RJ

Russell Alan J

Director, Chief Scientific OfficerCIK 0001853529

EDGAR filingsOpen in network
Disclosed transactions12
Buys / sells0 / 4
Max Insider Score42
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
5
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Grant or award
A—
65.0K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    Edgewise Therapeutics, Inc.Director, Chief Scientific Officer · Nov 13, 2025
17
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M
—
5,781 sh
Aug 12, 2026
Aug 14, 2026
traded Aug 12, 2026
+2d
SEC FORM 4

Evidence

13
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
7,031 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

5
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Grant or award
A—
32.5K sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

13
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
5,781 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

13
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
7,031 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

29
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$141K
3,238 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

29
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$99K
2,273 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

22
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$17K
390 sh
Aug 12, 2026Aug 14, 2026
traded Aug 12, 2026
+2dSEC FORM 4

Evidence

42
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Open-market sale
SELL$2.11M
100.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

13
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M—
100.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence

21
RJ
Russell Alan JDirector, Chief Scientific Officer
EWTXEdgewise Therapeutics, Inc.
Option exercise
M$18K
100.0K sh
Nov 12, 2025Nov 13, 2025
traded Nov 12, 2025
+1dSEC FORM 4

Evidence